期刊文献+

床旁即时凝血检测仪在抗凝治疗监测中的临床应用进展 被引量:5

Progress in clinical application of point-of-care testing device for antico-agulation monitoring
下载PDF
导出
摘要 与检验科凝血检测仪检测国际标准化比值(INR)比较,POCT凝血检测仪的准确度较好,精密度良好。用床旁即时(POCT)凝血检测仪最主要的优势在于能缩短检测周转时间,同时提高患者的满意度。不仅提高了患者华法林抗凝治疗的质量,而且减少了血栓栓塞事件和降低了全因死亡率,不增加出血事件的风险。同时,可以明显提高患者用药的依从性及生活质量。美国等国家由药师管理的抗凝门诊中,POCT凝血检测仪的应用,方便医务人员及时调整华法林的用药剂量,保证患者用药安全。若能进一步提高POCT凝血检测仪检测INR的准确度,会更好地服务于临床。 Compared with laboratory INR, good accuracy and precision are observed with POCT device. The primary advantages of POCT device is rapid turn-around time, improving patients' satisfaction at the same time. Using POCT device not only improves the gouality of Warfarin anticoagulant therapy, but also reduces thromboembolic events and mortality, without increased risk for a serious bleeding event. With the INR measured by POCT device, patient's medi- cation compliance and life quality will be improved significantly. In anticoagulation clinics of the country such as America are managed by pharmacists, with the application of POCT device, medical workers can adjust the dosage of Warfarin conveniently and ensure patients' medication safety. If the accuracy of POCT device is improved, it will be better for INR control in patients who taking Warfarin.
出处 《中国医药导报》 CAS 2015年第30期38-41,共4页 China Medical Herald
基金 国家临床重点专科建设项目(国卫办医函[2013]544号)
关键词 床旁即时 国际标准化比值 华法林 药剂师 Point-of-care International normalised ratio Warfarin Pharmacists
  • 相关文献

参考文献26

  • 1POCT临床应用建议[J].中华检验医学杂志,2012,35(1):10-16. 被引量:38
  • 2Perry DJ,Fitzmaurice DA,Kitchen S. Point-of-care testing in haemostasis[J].Br J Haematol, 2010, 150 ( 5) : 501- 514.
  • 3Meneqhelo ZM,Barroso CM,Liporace IL,et al. Comparison of the international normalized ratio levels obtained by' portable coagulometer and laboratory in a clinic specializing in oral anticoagulation[J]. Int J Lab Hematol, 2015,37 (4): 536-543.
  • 4孔莹,刘泽金,刘世国.床旁即时检测凝血仪的INR检测性能验证[J].诊断学理论与实践,2011,10(6):545-547. 被引量:2
  • 5Christensen TD, Larsen TB, Jensen C, et al. International normalised ratio(INR) measured on the CoaguChek Sand XS compared with the laboratory for determination of precision and accuracy[J]. Thromb Haemost, 2009, 10 1 (3) : 563-569.
  • 6黄珣钡,李思阅,王霞,孙勇,江虹.两种床旁实验凝血仪在换瓣术后抗凝监测中的临床应用[J].血栓与止血学,2013,19(6):274-276. 被引量:9
  • 7Larsson A,Greiq-Pylypczuk R,Huisman A. The state of point-of-care testingj a European perspective[J]. Ups J Med Sci, 2015,120(1): 1-10.
  • 8Dusse LM, Oliveira NC, Rios DR, et al. Point-of-care test (POCT) INR: hope or illusion?[J]. Rev Bras Cir Cardiovase ,2012 ,27(2): 296-301.
  • 9Bruch TP, Mendes DC, Pedrozo JC, et al. Is point-of-care accurate for indicating thrombolysis in anticoagulated patients on oral anticoagulation treatments?[J]. Arg Neuropsiquiatr ,2014, 72(7) :487-489.
  • 10Wardlaw JM,Murray V,Berge E,et al. Thrombolysis for acute ischaemic stroke[B]. Cochrane Database Syst Rev, 2014,7: CD000213.

二级参考文献51

  • 1潘柏申,杨振华,吴健民.冠状动脉疾病和心力衰竭时心脏标志物临床检测应用建议[J].中华检验医学杂志,2006,29(9):774-778. 被引量:73
  • 2Clinical laboratory testing and in vitro medical devicesRequirements for in vitro monitoring systems for selftesting of oral anticoagulant therapy[S/OL].ISO 17593:2007.[2011-10-25].http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=36872.
  • 3National Committee for Clinical Laboratory Standards.Collection,Transport,and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays; approved guideline-fourth Edition[S].H21-A4,CLSI,2003.[2011-10-25].http://www.clsi.org/source/orders/free/H21-aS.pdf.
  • 4Ansell J,Hirsh J,Poller L,et al.The pharmacology and management of the vitamin K antagonists:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126(3 Suppl):204S-233S.
  • 5Heneghan C,Alonso-Coello P,Garcia-Alamino JM,et al.Self-monitoring of oral anticoagulation: a systematic review and meta-analysis[J].Lancet,2006,367(9508):404-411.
  • 6Price CP,John A,Hicks JM.Point-of-Care Testing.Washington DC:AACC Press,2004.
  • 7NACB.Laboratory Medicine Practice Guidelines:Evidence-Based Practice for POCT.Washington DC:AACC Press,US.2007.
  • 8Price CP.Medical and Economic Outcomes of Point-of-Care Testing.Clin Chem Lab Med,2002,40:246-251.
  • 9CLSI.Point-of-care in Vitro Diagnostic (IVD) Testing; Approved standard.Document POCT 04-A2.Wayne,PA,CLS1,2006.
  • 10CLSI.Selection Criteria for Point-of Care Testing Devices;Approved Guideline.CLSI document POCT 09-A.Wayne,PA:CLSI,2010.

共引文献45

同被引文献23

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部